The FHIR Medical Device Protocol

FHIR can improve how medical devices exchange data, but it does not make a product secure by itself. For device manufacturers, the real question is whether a FHIR implementation supports safe interoperability without creating new attack paths, new privacy failures, or new regulatory problems.

Key Takeaways

• FHIR standardizes medical device data exchange.
• It requires secure system design, not just protocol use.
• Integrity and confidentiality are paramount for devices.
• Authenticate access, authorize usage, encrypt data.
• Validate data paths and manage dependencies.
• Document security controls for FDA submission.

Table of Contents

• Key Takeaways
• Why Cybersecurity Still Sits at the Center of Device Interoperability
• What FHIR Actually Is
• Why FHIR Fits Medical Device Communications
• Where FHIR Helps Security
• Data Integrity and Confidentiality Matter More Than API Convenience
• Implementing FHIR in Medical Devices Without Creating New Risk
• What This Means for the FDA and Device Manufacturers
• The Long View: Better Interoperability, Better Security Discipline
• Related FDA & cybersecurity guides

Why this matters

The security implications of the FHIR medical device protocol are substantial because connected devices are integral to modern healthcare, moving critical data that directly impacts patient care. Weak security within these systems can lead to compromised therapy delivery, alarm failures, and clinical decision-making errors. The FDA's 'Cybersecurity in Medical Devices' Final Guidance, dated February 3, 2026, emphasizes the necessity of secure device design, authenticated communications, patching strategies, and access controls to mitigate these risks. Device manufacturers must ensure that FHIR adoption enhances interoperability without introducing new attack surfaces or compromising data integrity and confidentiality. Adherence to standards like IEC 80001-1, ISO 14971, and AAMI TIR57 is crucial for managing cybersecurity risks in the context of integrating devices into IT networks. The integrity and authenticity of medical device data are paramount, necessitating careful validation of data paths, dependency management, and robust documentation of security controls for regulatory submissions. For healthcare delivery organizations, this translates to demanding secure by design devices and implementing rigorous monitoring and incident response protocols.

Why Cybersecurity Still Sits at the Center of Device Interoperability

Connected medical devices are now part of routine care. Infusion pumps, cardiac implants, bedside monitors, imaging systems, and remote monitoring platforms all depend on moving data between devices, applications, cloud services, and clinical systems. That connectivity improves care. It also expands the attack surface.

When a device is exposed to hospital networks, mobile applications, APIs, or third-party integrations, the consequences of weak security are no longer limited to data loss. A compromise can affect therapy delivery, alarm integrity, device availability, and clinical decision-making. That is why cybersecurity for medical devices cannot be treated as an IT afterthought or a documentation exercise.

Manufacturers and healthcare delivery organizations both have work to do. Devices need secure design, authenticated communications, patching strategies, and access controls that hold up in real environments. Organizations using those devices need segmentation, monitoring, incident response, and procurement standards that go beyond checkbox language.

The threat picture is not theoretical. Healthcare continues to see ransomware, credential attacks, vulnerable remote access paths, third-party software risk, and exploitation of unpatched systems. If a device communicates through modern APIs, those APIs need the same level of scrutiny as any other externally reachable interface.

What FHIR Actually Is

FHIR (Fast Healthcare Interoperability Resources) is a standard for exchanging healthcare information electronically. It defines data structures, workflows, and API patterns so systems can share clinical information in a more consistent way.

That matters for medical devices because device data often needs to move into EHRs, dashboards, analytics platforms, remote monitoring systems, and clinician workflows. FHIR gives manufacturers a common model for representing and exchanging that information instead of relying on brittle custom integrations.

FHIR is widely adopted because it aligns with modern web technologies. It supports formats such as JSON and XML and commonly uses RESTful APIs. That makes implementation more practical than older interface approaches in many settings. It also means security has to be handled with the same seriousness you would apply to any internet-connected API ecosystem.

Why FHIR Fits Medical Device Communications

FHIR is attractive for device interoperability for a few simple reasons.

First, it is modular. Data is organized into resources, which makes it easier to expose or consume only what is needed for a given workflow.

Second, it is easier to integrate with current software stacks than many legacy healthcare protocols. That lowers friction for connecting devices to hospital applications, cloud services, and patient-facing tools.

Third, it can be extended. That flexibility helps when manufacturers need to represent device-specific data elements or workflows. But it also creates a governance issue: extensions that are poorly designed, weakly documented, or inconsistently implemented can break interoperability and complicate security review.

FHIR is useful. It is not magic. A bad architecture built on FHIR is still a bad architecture.

Where FHIR Helps Security

FHIR can support better security outcomes when it is implemented correctly. It gives teams a more standardized way to handle data exchange, which reduces some of the guesswork and inconsistency that often show up in one-off integrations.

For medical device manufacturers, the security value comes from how FHIR-based interfaces can be paired with strong controls such as:

• authenticated access to APIs
• role-based or context-based authorization
• encryption in transit
• audit logging
• integrity checks on exchanged data
• constrained exposure of only necessary resources and operations

Used well, those controls can reduce the chance of unauthorized access, silent data manipulation, and poorly governed data sharing.

FHIR can also improve traceability. Standardized APIs and data models make it easier to understand what data is moving, who should have access to it, and where logging needs to occur. That helps with security operations, postmarket monitoring, and regulatory documentation.

Still, none of this is automatic. FHIR does not guarantee secure authentication. It does not guarantee least privilege. It does not guarantee safe implementation of tokens, sessions, gateways, mobile apps, or cloud connectors. Security depends on the system design around the protocol.

Data Integrity and Confidentiality Matter More Than API Convenience

Too many interoperability discussions focus on ease of integration and skip the harder question: can clinicians trust the data, and can the manufacturer defend the system under attack?

For medical devices, data integrity is often more important than convenience. If transmitted values are altered, delayed, replayed, mismatched to the wrong patient or device, or pulled from an untrusted source, the issue is not just privacy. It can become a patient safety problem.

FHIR can help support integrity and confidentiality because it standardizes data exchange and makes interface behavior more predictable. That predictability is useful for validation, monitoring, and access control design. It also helps reduce the messy translation layers that often introduce errors or undocumented behavior.

This is where manufacturers need discipline. If your device or companion system exposes FHIR endpoints, you need to know:

• what data is exposed
• who can request it
• how identities are verified
• how authorization is enforced
• how requests and responses are logged
• how integrity issues are detected
• what happens when dependent services fail or degrade

See also: GET vs POST for Medical Device APIs: Security Best Practices, Key Exchange in Medical Device Cybersecurity, and OWASP Top 10:2025 for Medical Device Cybersecurity.

Those are product security questions, not just interoperability questions.

Implementing FHIR in Medical Devices Without Creating New Risk

Implementing FHIR in a device ecosystem takes planning. The protocol itself is not the hard part. The hard part is integrating it into a safe and defensible product architecture.

Manufacturers should start by designing with cybersecurity in mind from the beginning. That means secure coding, threat modeling, dependency management, authentication design, secrets handling, software bill of materials visibility, and validation of data flows between device components and external systems. It also means understanding how the interface could be misused, not just how it is supposed to work.

A practical FHIR integration effort usually includes:

• defining the minimum necessary data exchange
• mapping device data to appropriate FHIR resources
• identifying trust boundaries and external dependencies
• securing API access and identity flows
• testing failure modes, malformed requests, and abuse cases
• validating logs, alerts, and recovery behavior
• documenting security controls for internal review and regulatory use

Healthcare organizations deploying FHIR-enabled devices also need operating procedures for configuration, credential management, updates, network placement, and incident response. A secure product can still be deployed badly.

Common implementation problems

The biggest problems are usually not the standard itself. They are the shortcuts around it.

Legacy systems can create compatibility headaches. Cloud-connected architectures can increase exposure if interfaces are opened without proper segmentation or monitoring. Extensions can become a mess if they are not governed. Privacy obligations can be missed when teams expose more data than a workflow actually requires.

There is also a recurring mistake in device development: treating interoperability as a feature and cybersecurity as a separate compliance workstream. That approach fails under scrutiny. The FDA expects cybersecurity to be built into device design, risk management, and lifecycle maintenance. If your FHIR interface changes the risk profile of the device, that needs to show up in your analysis, your testing, and your documentation.

What This Means for the FDA and Device Manufacturers

For manufacturers, FHIR adoption should be tied to product security evidence, not marketing language. If a device uses FHIR-based communications, you should be ready to explain how that interface is authenticated, how misuse is constrained, how updates are managed, and how security risk was assessed across the device system.

That matters during design reviews, customer security assessments, and FDA submission preparation. It also matters after release. Postmarket issues often show up in integrations, remote services, third-party components, and configuration drift, not just in the embedded device itself.

FHIR can support safer interoperability. But if it increases connectivity without a matching investment in architecture, monitoring, and lifecycle controls, it simply gives attackers another route in.

The Long View: Better Interoperability, Better Security Discipline

FHIR will remain part of the healthcare technology stack because the need for cleaner data exchange is not going away. For medical devices, that is a good thing. Better standards can reduce custom integrations, improve consistency, and make security review more manageable.

The long-term benefit is not just easier connectivity. It is the chance to build device ecosystems that are easier to understand, test, secure, and maintain. That only happens when manufacturers treat interoperability as a security-relevant design choice from day one.

If you are adopting FHIR, do it with discipline. Define the use case. Limit exposure. Validate the data path. Test abuse cases. Document the controls. And make sure your security story would stand up to both customers and the FDA.

Blue Goat Cyber helps medical device manufacturers assess connected product risk, strengthen security design, and prepare for real regulatory scrutiny. If your team is building or deploying FHIR-enabled capabilities, contact us today for cybersecurity help.

How Blue Goat approaches this

Blue Goat Cyber helps medical device manufacturers implement FHIR securely and meet regulatory requirements. Our team, comprised of CISSPs, OSCPs, and ex-military red team members, focuses on identifying and mitigating risks introduced by new communication protocols. We conduct in-depth threat modeling specific to FHIR-enabled devices, perform penetration testing, and validate security controls for data integrity, confidentiality, and availability. Our approach involves evaluating authentication, authorization, encryption, and audit logging mechanisms to ensure they align with the FDA's expectations. We work to integrate security into every stage of the product lifecycle, from design to postmarket oversight. If the FDA raises cybersecurity deficiencies after our submission, we resolve them at no additional cost. Learn more about our services at Medical Device Penetration Testing.

FAQ

What is FHIR?

FHIR (Fast Healthcare Interoperability Resources) is a standard for exchanging healthcare information electronically. It defines data structures, workflows, and API patterns for consistent clinical data sharing among systems.

How does FHIR improve medical device cybersecurity?

FHIR can improve cybersecurity by standardizing interfaces, which facilitates the implementation of strong controls like authenticated access, role-based authorization, encryption, and audit logging. This makes it easier to track and secure data flows.

Does FHIR make medical devices secure by default?

No, FHIR does not inherently make medical devices secure. Security depends on how FHIR is implemented within a product's architecture, including secure coding practices, threat modeling, and strong access controls.

What should manufacturers consider when implementing FHIR?

Manufacturers should define minimum necessary data exchange, map device data to FHIR resources, secure API access, test failure modes, and rigorously document security controls for FDA submission and postmarket monitoring.

How does the FDA view FHIR implementation in medical devices?

The FDA expects cybersecurity to be built into device design, risk management, and lifecycle maintenance. Manufacturers using FHIR must demonstrate how the interface is authenticated, how misuse is constrained, and how security risk was assessed across the device system, as outlined in the February 3, 2026 final guidance.

What are common pitfalls when using FHIR for medical devices?

Common pitfalls include treating interoperability as only a feature, neglecting secure architecture around the protocol, poorly governed extensions, and failing to manage cloud or legacy system compatibility challenges.

Related FDA & cybersecurity guides

• FDA Section 524B cybersecurity requirements explained
• SBOM vulnerability management for medical devices
• VEX document guide for FDA submissions
• FDA deficiency-letter response service
• STRIDE threat modeling for medical devices

About the author

Christian Espinosa, CISSP, Founder, Blue Goat Cyber. Christian leads a team focused exclusively on medical device cybersecurity for FDA premarket submissions and postmarket compliance. Read more about Christian.